Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지

Caloric Restriction vs Testosterone Treatment ; The Effect on Body Fat Distribution and Serum Lipid Levels in Overweight Male Patients with Coronary Artery Disease

관상동맥경화증인 과체중 남성에서 열량제한과 Testosterone 투여가 체지방 분포 및 혈청 지질 농도에 미치는 영향

  • 이종호 (연세대학교 생활과학대학 식품영양학과) ;
  • 채지숙 (연세대학교 노화과학연구소) ;
  • 고수정 (연세대학교 생활과학대학 식품영양학과) ;
  • 강석민 (연세대학교 의과대학 심장내과) ;
  • 최동훈 (연세대학교 의과대학 심장내과) ;
  • 장양수 (연세대학교 의과대학 심장내과)
  • Published : 2003.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

In middle-aged men, abdominal obesity has been an important risk factor of coronary artery disease (CAD) as well as a predictor of hypertension, dyslipidemia, insulin resistance and glucose intolerance. Particularly, risks from abdominal obesity increase when adipose tissue accumulates in visceral compartment. Many studies showed that weight reduction by caloric restriction improves abdominal obesity and reduces lots of cardiovascular risk factors. Testosterone treatment also results in a significant decrease in visceral fat area and normalizes endocrine metabolism. However there is no study that compare the effect of caloric restriction with that of testosterone treatment. The purpose of this study is to investigate the effect of caloric restriction and that of testosterone treatment on body fat distribution, serum lipids and glucose metabolism in male patients with CAD. Forty five middle-aged overweight-obese men with CAD participated in 12 weeks' program. They were matched with age, body weight, body mass index (BMI) and divided into three groups : control group (n = 15) , caloric restriction group (-300 kcal/day, n = 15) and testosterone treatment group (testosterone undecanoate tablets, n = 15) . After 12 weeks, control group did not have any changes in anthropometries, lipid profile, body fat distribution, glucose metabolism and hormonal status. Expectedly, caloric restriction group showed decreases in body weight, BMI, waist to hip ratio, ％ body fat. Ten percentage of total cholesterol and 23% of triglyceride in serum were also decreased. In body fat distribution, total fat areas at both L1 and L4 levels were significantly reduced in this group without reduction in muscle of thigh and calf. However, testosterone treatment group did not have any significant changes in body weight, ％ body fat, serum lipid profile and abdominal fat distribution. In conclusion, weight reduction by caloric restriction is more beneficial in body fat distribution and serum lipid level than testosterone treatment in overweight male patients with CAD. This result suggests that modest weight reduction is possible to help decrease risk factors of CAD.

Keywords

References

  1. Am J Clin Nutr v.60 no.5 Obesity and reglonal body-fat distribution in men: Separate and joint relationships to glucose tolerance and plasma lipoproteins zamboni,M.;Armellini,F.;Cominacini,L.;Turcato,E.;Todesco,T.;Bissoli,L.;Micciolo,R.;Bergamo-Andreis,I.A.;Boselio,O.
  2. Am J Cardiol v.72 no.5 Insulin resistance, glucose intolerance, hyperinsulinermia and dyslipidemia in patients with angiographically demonstrated coronary artery disease Young,M.H.;Jeng,C.;Sheu,W.H.;Shieh,S.M;Fuh,M.M.;Chen,Y.D.;Reaven,G.M. https://doi.org/10.1016/0002-9149(93)91141-4
  3. J Clin Endocrinol Metab v.54 no.2 Relation of body fat distribution to metabolic complications of obesity Kissebah,A.H.;Vydelingum,N.;Murray,R.;Evans,D.J.;hartz,A.J.;Kalkhoff,R.K.;Adams,P.W. https://doi.org/10.1210/jcem-54-2-254
  4. Endocr Rev v.14 no.1 Genetic and nongenetic determinants of regional fat distribution Buchard,C.;Despress,J.;Mauriege,P.
  5. Recent Prog Med v.82 no.2 Obesity: relationships with the endocrine system Alboni,S.;Riva,P.;bellini,M.;Bonati,M.E.;sacchetti,C.;Calzolari,G.;Grandi,M.
  6. Metabolism v.40 no.1 Effect of obesity and body fat distribution on sex hormones and insulin in men Pasquali,R.;Casimirri,F.;Cantobeli,S.;Melchionda,N.;Morselli;Labate,A.M.;Fabbri,R.;Capelli,M.;Bortoluzzi,L. https://doi.org/10.1016/0026-0495(91)90199-7
  7. Int J Obes Relat Metab Disord v.20 no.4 The regulation of adipose tissue distribution in humans Bjorntorp,P.
  8. Metabolism v.39 no.9 Visceral fat accumulation in men is positively associated with insulin glucose and C-peptide levels, but negatively with testosterone level Seidell,J.C.;Bjorntorp,P.;Sjostorm,L.;Kvist,H.;Sannerstedt,R. https://doi.org/10.1016/0026-0495(90)90297-P
  9. Int J Obes Relat Metab Disord v.24 no.4 Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men Tsai,E.C.;Boyko,E.J.;Leonetti,D.L.;Fujimoto,W.Y, https://doi.org/10.1038/sj.ijo.0801183
  10. Int J Obes Relat Metab Disord v.19 Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men Lovejoy,J.C.;Bray,G.A.;Greeson,C.S.;Klemperer,M.;Morris,J.;Patington,C.;Tulley,R.
  11. Curr Opin Lipidol v.5 no.3 Fatty acids, hyperinsulinemia and insulin resistance: which comes first? Curr Opin Lipidol Bjorntorp,P. https://doi.org/10.1097/00041433-199405030-00003
  12. Arteriosclerosis v.10 no.4 "Portal" adipose tissue as a generator of risk gactors for cardiovascular disease and diabetes Bjorntorp,P. https://doi.org/10.1161/01.ATV.10.4.493
  13. Int J Obes v.14 no.4 Associations between regional body fat distribution, fasting plasma free fatty acid levels and glucose tolerance in premenopausal women Pouliot,M.C.;Despres,J.P.;Nadeau,A.;Tremblay,A.;Moorjani,S.;Lupien,P.J.;Theriault,G.;Bouchard,C.
  14. Diabetes Care v.14 no.3 Insulin resistance. A multifaccted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease DeFronzo,R.A.;Ferrannini,E. https://doi.org/10.2337/diacare.14.3.173
  15. Physiol Rev v.74 no.4 Regional adiposity and morbidity Kissebah,A.H.;Krakower,G.R.
  16. Am J Clin Nutr v.56 no.2 Effect of weight reduction on blood lipids and lipoproteins: a meta-analysis Dattilo,A.M.;Kris-Etherton,P.M.
  17. J Chronic Dis v.27 no.3 Relation of weight change to changes in atherogenic traits: the Framingham study Ashley,F.W.;Kannel,W.B. https://doi.org/10.1016/0021-9681(74)90079-4
  18. Clin Chem v.18 no.6 Estimation of he concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Friedewald,W.T.;Levy,R.I.;Fredrickason,D.S.
  19. Metabolism v.32 no.5 relationship of plasma HDL-cholesterol to testosterone, estradiol and sex hormone binding globulins in men and women Semmens,J.;Rouse,I.;Belin,L.J.;Masarei,R.L. https://doi.org/10.1016/0026-0495(83)90002-1
  20. Prog Cardiovasc Dis v.38 no.3 Androgen and progestagen effects on plasma lipids Bagatell,C.J.;Bremner,W.J. https://doi.org/10.1016/S0033-0620(95)80016-6
  21. Int J Obes Relat Metab Disord v.16 no.12 The effects of testosterone treatment on body composition and metabolism in middle-aged men Marin,P.;Holmang,S.;Jonsson,L.;Sjostrom,L.;Kvist,H.;Holm,G.;Lindstedt,G.;Bjorntorp,P.
  22. Obes Res v.3 no.SUP 4 testosterone and regional fat distribution Marin,P. https://doi.org/10.1002/j.1550-8528.1995.tb00197.x
  23. J Clin Endocrinol Metab v.81 no.12 Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss Havel,P.J.;Kasim-Karakas,S.;Mueller,W.;Johnson,P.R.;Gingerich,R.L.;Stern,J.S. https://doi.org/10.1210/jc.81.12.4406
  24. J Clin Endocrinol Metab v.81 no.12 Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism Katznelson,L.;Finkelstein,J.S.;Schoenfeld,D.A.;Rosenthal,D.I.;Anderson,E.J.;Klibanski,A. https://doi.org/10.1210/jc.81.12.4358
  25. J Clin Endocrinol Metab v.81 no.10 Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men-a clinical research center study Brodsky,I.G.;Balagopal,P.;Nair,K.S. https://doi.org/10.1210/jc.81.10.3469
  26. J Clin Endocrinol Metab v.84 no.8 Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age Snyder,P.J.;Peachey,H.;Hannoush,P.;Berlin,J.A.;Loh,L.;Lenrow,D.A.;Holmes,J.H.;Dlewati,A.;Santanna,J.;Rosen,C.J.Strom,B.L. https://doi.org/10.1210/jc.84.8.2647
  27. J Clin Endocrinol Metab v.81 no.10 sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men-a clinical research center study Wang,C.;Eyre,D.R.;Clark,R.;kleinberg,D.;Newman,C.;Iranmanesh,A.;Veldhuis,J.;Dudley,R.E.;Berman,N.;Davidson,T.;Barstow,T.J.;Sinow,R.;Alexander,G.;Swerdlof,R.S. https://doi.org/10.1210/jc.81.10.3654
  28. J Clin Endocrinol Metab v.85 no.8 Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group Wang,C.;Swedloff,R.S.;Iranmanesh,A.Dobs,A.;Snyder,P.J.;Cunningham,G.;Matsumoto,A.M.;Weger,T.;Berman,N. https://doi.org/10.1210/jc.85.8.2839